Liangdan Sun

Title: Innovations and Contributions of Inventor Liangdan Sun

Introduction

Liangdan Sun is a notable inventor based in Hefei, China. He has made significant contributions to the field of medicine, particularly in the development of treatments for psoriasis and protein inhibitory medicines. With a total of 4 patents, his work showcases a commitment to advancing medical science.

Latest Patents

Liangdan Sun's latest patents include innovative applications of CaMK4 in the preparation of medicines for preventing and treating psoriasis. His research indicates that CaMK4 is positively correlated with the development of psoriasis, as it is expressed in both immune cells and keratinocytes. Furthermore, his findings suggest that both IL-10 and a CaMK4 inhibitor can reduce psoriasiform inflammation induced by IMQ in mice. This positions CaMK4 as a promising new target for psoriasis treatment.

Another significant patent involves the use of a compound or medicinal derivative in inhibiting AIM2 protein activity. This compound demonstrates a strong targeting effect compared to traditional broad-spectrum immunomodulators. It has shown advantages such as easy storage, stable activity, and lower production costs, making it a valuable addition to the field of protein inhibitory medicines.

Career Highlights

Throughout his career, Liangdan Sun has worked with various organizations, contributing to the advancement of medical research. His innovative approaches and dedication to his work have established him as a respected figure in his field.

Collaborations

Liangdan Sun has collaborated with notable colleagues, including Qi Zhen and Weiwei Chen. These partnerships have further enhanced his research and contributions to medical science.

Conclusion

Liangdan Sun's work exemplifies the impact of innovation in medicine, particularly in the treatment of psoriasis and protein inhibition. His patents reflect a deep understanding of complex biological processes and a commitment to developing effective medical solutions.